 | • レポートコード：D005-06322 • 出版社/出版日：GlobalInfoResearch / 2020年5月22日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、138ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、眼薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。眼薬の種類別市場規模（点液、タブレット＆カプセル）、用途別市場規模（緑内障、網膜疾患、細菌感染症、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Pfizer、SANDOZ、Laboratoire Riva、Novartis、Teva Pharmaceutical?、bausch Lomb、Mylan、Fresenius、Jamp Pharma、Greenstone、Actavis、GE Medical、APOTEX、Taj Pharmaceuticals、Mint Pharmaceuticals、Sun Pharma、Laboratoires Thea ・地域別グローバル市場分析 2015年-2020年 ・眼薬の北米市場（アメリカ、カナダ、メキシコ） ・眼薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・眼薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・眼薬の南米市場（ブラジル、アルゼンチン） ・眼薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：点液、タブレット＆カプセル ・用途別分析：緑内障、網膜疾患、細菌感染症、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Eye Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Eye Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Eye Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Eye Drug market has been segmented into
Drops
Tablet & Capsule
By Application, Eye Drug has been segmented into:
Glaucoma
Retinal Disease
Bacterial?Infection
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Eye Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Eye Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Eye Drug market.
The report offers in-depth assessment of the growth and other aspects of the Eye Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Eye Drug Market Share Analysis
Eye Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Eye Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Eye Drug sales, revenue and market share for each player covered in this report.
The major players covered in Eye Drug are:
Pfizer
SANDOZ
Laboratoire Riva
Novartis
Teva Pharmaceutical?
bausch Lomb
Mylan
Fresenius
Jamp Pharma
Greenstone
Actavis
GE Medical
APOTEX
Taj Pharmaceuticals
Mint Pharmaceuticals
Sun Pharma
Laboratoires Thea
Among other players domestic and global, Eye Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Eye Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Eye Drug, with price, sales, revenue and global market share of Eye Drug in 2018 and 2019.
Chapter 3, the Eye Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Eye Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Eye Drug market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Eye Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Eye Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Eye Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Drops
1.2.3 Tablet & Capsule
1.3 Market Analysis by Application
1.3.1 Overview: Global Eye Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Glaucoma
1.3.3 Retinal Disease
1.3.4 Bacterial?Infection
1.3.5 Other
1.4 Overview of Global Eye Drug Market
1.4.1 Global Eye Drug Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Eye Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 SANDOZ
2.2.1 SANDOZ Details
2.2.2 SANDOZ Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 SANDOZ SWOT Analysis
2.2.4 SANDOZ Product and Services
2.2.5 SANDOZ Eye Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Laboratoire Riva
2.3.1 Laboratoire Riva Details
2.3.2 Laboratoire Riva Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Laboratoire Riva SWOT Analysis
2.3.4 Laboratoire Riva Product and Services
2.3.5 Laboratoire Riva Eye Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Novartis SWOT Analysis
2.4.4 Novartis Product and Services
2.4.5 Novartis Eye Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Teva Pharmaceutical?
2.5.1 Teva Pharmaceutical? Details
2.5.2 Teva Pharmaceutical? Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Teva Pharmaceutical? SWOT Analysis
2.5.4 Teva Pharmaceutical? Product and Services
2.5.5 Teva Pharmaceutical? Eye Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 bausch Lomb
2.6.1 bausch Lomb Details
2.6.2 bausch Lomb Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 bausch Lomb SWOT Analysis
2.6.4 bausch Lomb Product and Services
2.6.5 bausch Lomb Eye Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Mylan
2.7.1 Mylan Details
2.7.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Mylan SWOT Analysis
2.7.4 Mylan Product and Services
2.7.5 Mylan Eye Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Fresenius
2.8.1 Fresenius Details
2.8.2 Fresenius Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Fresenius SWOT Analysis
2.8.4 Fresenius Product and Services
2.8.5 Fresenius Eye Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Jamp Pharma
2.9.1 Jamp Pharma Details
2.9.2 Jamp Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Jamp Pharma SWOT Analysis
2.9.4 Jamp Pharma Product and Services
2.9.5 Jamp Pharma Eye Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Greenstone
2.10.1 Greenstone Details
2.10.2 Greenstone Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Greenstone SWOT Analysis
2.10.4 Greenstone Product and Services
2.10.5 Greenstone Eye Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Actavis
2.11.1 Actavis Details
2.11.2 Actavis Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Actavis SWOT Analysis
2.11.4 Actavis Product and Services
2.11.5 Actavis Eye Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 GE Medical
2.12.1 GE Medical Details
2.12.2 GE Medical Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 GE Medical SWOT Analysis
2.12.4 GE Medical Product and Services
2.12.5 GE Medical Eye Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 APOTEX
2.13.1 APOTEX Details
2.13.2 APOTEX Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 APOTEX SWOT Analysis
2.13.4 APOTEX Product and Services
2.13.5 APOTEX Eye Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Taj Pharmaceuticals
2.14.1 Taj Pharmaceuticals Details
2.14.2 Taj Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Taj Pharmaceuticals SWOT Analysis
2.14.4 Taj Pharmaceuticals Product and Services
2.14.5 Taj Pharmaceuticals Eye Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Mint Pharmaceuticals
2.15.1 Mint Pharmaceuticals Details
2.15.2 Mint Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Mint Pharmaceuticals SWOT Analysis
2.15.4 Mint Pharmaceuticals Product and Services
2.15.5 Mint Pharmaceuticals Eye Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Sun Pharma
2.16.1 Sun Pharma Details
2.16.2 Sun Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Sun Pharma SWOT Analysis
2.16.4 Sun Pharma Product and Services
2.16.5 Sun Pharma Eye Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Laboratoires Thea
2.17.1 Laboratoires Thea Details
2.17.2 Laboratoires Thea Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Laboratoires Thea SWOT Analysis
2.17.4 Laboratoires Thea Product and Services
2.17.5 Laboratoires Thea Eye Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Eye Drug Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Eye Drug Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Eye Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Eye Drug Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Eye Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Eye Drug Sales and Market Share by Regions (2015-2020)
4.1.2 Global Eye Drug Revenue and Market Share by Regions (2015-2020)
4.2 North America Eye Drug Sales and Growth Rate (2015-2020)
4.3 Europe Eye Drug Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Eye Drug Sales and Growth Rate (2015-2020)
4.5 South America Eye Drug Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Eye Drug Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Eye Drug Sales, Revenue and Market Share by Country
5.1.1 North America Eye Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Eye Drug Revenue and Market Share by Country (2015-2020)
5.2 United States Eye Drug Sales and Growth Rate (2015-2020)
5.3 Canada Eye Drug Sales and Growth Rate (2015-2020)
5.4 Mexico Eye Drug Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Eye Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Eye Drug Sales and Market Share by Country (2015-2020)
6.1.2 Europe Eye Drug Revenue and Market Share by Country (2015-2020)
6.2 Germany Eye Drug Sales and Growth Rate (2015-2020)
6.3 UK Eye Drug Sales and Growth Rate (2015-2020)
6.4 France Eye Drug Sales and Growth Rate (2015-2020)
6.5 Russia Eye Drug Sales and Growth Rate (2015-2020)
6.6 Italy Eye Drug Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Eye Drug Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Eye Drug Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Eye Drug Revenue and Market Share by Regions (2015-2020)
7.2 China Eye Drug Sales and Growth Rate (2015-2020)
7.3 Japan Eye Drug Sales and Growth Rate (2015-2020)
7.4 Korea Eye Drug Sales and Growth Rate (2015-2020)
7.5 India Eye Drug Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Eye Drug Sales and Growth Rate (2015-2020)
7.7 Australia Eye Drug Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Eye Drug Sales, Revenue and Market Share by Country
8.1.1 South America Eye Drug Sales and Market Share by Country (2015-2020)
8.1.2 South America Eye Drug Revenue and Market Share by Country (2015-2020)
8.2 Brazil Eye Drug Sales and Growth Rate (2015-2020)
8.3 Argentina Eye Drug Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Eye Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Eye Drug Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Eye Drug Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Eye Drug Sales and Growth Rate (2015-2020)
9.3 Turkey Eye Drug Sales and Growth Rate (2015-2020)
9.4 Egypt Eye Drug Sales and Growth Rate (2015-2020)
9.5 South Africa Eye Drug Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Eye Drug Sales and Market Share by Type (2015-2020)
10.2 Global Eye Drug Revenue and Market Share by Type (2015-2020)
10.3 Global Eye Drug Price by Type (2015-2020)
11 Global Eye Drug Market Segment by Application
11.1 Global Eye Drug Sales Market Share by Application (2015-2020)
11.2 Global Eye Drug Revenue Market Share by Application (2015-2020)
11.3 Global Eye Drug Price by Application (2015-2020)
12 Market Forecast
12.1 Global Eye Drug Sales, Revenue and Growth Rate (2021-2025)
12.2 Eye Drug Market Forecast by Regions (2021-2025)
12.2.1 North America Eye Drug Market Forecast (2021-2025)
12.2.2 Europe Eye Drug Market Forecast (2021-2025)
12.2.3 Asia-Pacific Eye Drug Market Forecast (2021-2025)
12.2.4 South America Eye Drug Market Forecast (2021-2025)
12.2.5 Middle East & Africa Eye Drug Market Forecast (2021-2025)
12.3 Eye Drug Market Forecast by Type (2021-2025)
12.3.1 Global Eye Drug Sales Forecast by Type (2021-2025)
12.3.2 Global Eye Drug Market Share Forecast by Type (2021-2025)
12.4 Eye Drug Market Forecast by Application (2021-2025)
12.4.1 Global Eye Drug Sales Forecast by Application (2021-2025)
12.4.2 Global Eye Drug Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Eye Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Eye Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Eye Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Eye Drug Major Business
Table 9. Pfizer Eye Drug Total Revenue (USD Million) (2017-2018)
Table 10. Pfizer SWOT Analysis
Table 11. Pfizer Eye Drug Product and Services
Table 12. Pfizer Eye Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. SANDOZ Basic Information, Manufacturing Base and Competitors
Table 14. SANDOZ Eye Drug Major Business
Table 15. SANDOZ Eye Drug Total Revenue (USD Million) (2017-2018)
Table 16. SANDOZ SWOT Analysis
Table 17. SANDOZ Eye Drug Product and Services
Table 18. SANDOZ Eye Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Laboratoire Riva Basic Information, Manufacturing Base and Competitors
Table 20. Laboratoire Riva Eye Drug Major Business
Table 21. Laboratoire Riva Eye Drug Total Revenue (USD Million) (2017-2018)
Table 22. Laboratoire Riva SWOT Analysis
Table 23. Laboratoire Riva Eye Drug Product and Services
Table 24. Laboratoire Riva Eye Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Novartis Basic Information, Manufacturing Base and Competitors
Table 26. Novartis Eye Drug Major Business
Table 27. Novartis Eye Drug Total Revenue (USD Million) (2017-2018)
Table 28. Novartis SWOT Analysis
Table 29. Novartis Eye Drug Product and Services
Table 30. Novartis Eye Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Teva Pharmaceutical? Basic Information, Manufacturing Base and Competitors
Table 32. Teva Pharmaceutical? Eye Drug Major Business
Table 33. Teva Pharmaceutical? Eye Drug Total Revenue (USD Million) (2017-2018)
Table 34. Teva Pharmaceutical? SWOT Analysis
Table 35. Teva Pharmaceutical? Eye Drug Product and Services
Table 36. Teva Pharmaceutical? Eye Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. bausch Lomb Basic Information, Manufacturing Base and Competitors
Table 38. bausch Lomb Eye Drug Major Business
Table 39. bausch Lomb Eye Drug Total Revenue (USD Million) (2017-2018)
Table 40. bausch Lomb SWOT Analysis
Table 41. bausch Lomb Eye Drug Product and Services
Table 42. bausch Lomb Eye Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Mylan Basic Information, Manufacturing Base and Competitors
Table 44. Mylan Eye Drug Major Business
Table 45. Mylan Eye Drug Total Revenue (USD Million) (2017-2018)
Table 46. Mylan SWOT Analysis
Table 47. Mylan Eye Drug Product and Services
Table 48. Mylan Eye Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Fresenius Basic Information, Manufacturing Base and Competitors
Table 50. Fresenius Eye Drug Major Business
Table 51. Fresenius Eye Drug Total Revenue (USD Million) (2017-2018)
Table 52. Fresenius SWOT Analysis
Table 53. Fresenius Eye Drug Product and Services
Table 54. Fresenius Eye Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Jamp Pharma Basic Information, Manufacturing Base and Competitors
Table 56. Jamp Pharma Eye Drug Major Business
Table 57. Jamp Pharma Eye Drug Total Revenue (USD Million) (2017-2018)
Table 58. Jamp Pharma SWOT Analysis
Table 59. Jamp Pharma Eye Drug Product and Services
Table 60. Jamp Pharma Eye Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Greenstone Basic Information, Manufacturing Base and Competitors
Table 62. Greenstone Eye Drug Major Business
Table 63. Greenstone Eye Drug Total Revenue (USD Million) (2017-2018)
Table 64. Greenstone SWOT Analysis
Table 65. Greenstone Eye Drug Product and Services
Table 66. Greenstone Eye Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Actavis Basic Information, Manufacturing Base and Competitors
Table 68. Actavis Eye Drug Major Business
Table 69. Actavis Eye Drug Total Revenue (USD Million) (2017-2018)
Table 70. Actavis SWOT Analysis
Table 71. Actavis Eye Drug Product and Services
Table 72. Actavis Eye Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. GE Medical Basic Information, Manufacturing Base and Competitors
Table 74. GE Medical Eye Drug Major Business
Table 75. GE Medical Eye Drug Total Revenue (USD Million) (2017-2018)
Table 76. GE Medical SWOT Analysis
Table 77. GE Medical Eye Drug Product and Services
Table 78. GE Medical Eye Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. APOTEX Basic Information, Manufacturing Base and Competitors
Table 80. APOTEX Eye Drug Major Business
Table 81. APOTEX Eye Drug Total Revenue (USD Million) (2017-2018)
Table 82. APOTEX SWOT Analysis
Table 83. APOTEX Eye Drug Product and Services
Table 84. APOTEX Eye Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Taj Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 86. Taj Pharmaceuticals Eye Drug Major Business
Table 87. Taj Pharmaceuticals Eye Drug Total Revenue (USD Million) (2017-2018)
Table 88. Taj Pharmaceuticals SWOT Analysis
Table 89. Taj Pharmaceuticals Eye Drug Product and Services
Table 90. Taj Pharmaceuticals Eye Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Mint Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 92. Mint Pharmaceuticals Eye Drug Major Business
Table 93. Mint Pharmaceuticals Eye Drug Total Revenue (USD Million) (2017-2018)
Table 94. Mint Pharmaceuticals SWOT Analysis
Table 95. Mint Pharmaceuticals Eye Drug Product and Services
Table 96. Mint Pharmaceuticals Eye Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. Sun Pharma Basic Information, Manufacturing Base and Competitors
Table 98. Sun Pharma Eye Drug Major Business
Table 99. Sun Pharma Eye Drug Total Revenue (USD Million) (2017-2018)
Table 100. Sun Pharma SWOT Analysis
Table 101. Sun Pharma Eye Drug Product and Services
Table 102. Sun Pharma Eye Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 103. Laboratoires Thea Basic Information, Manufacturing Base and Competitors
Table 104. Laboratoires Thea Eye Drug Major Business
Table 105. Laboratoires Thea Eye Drug Total Revenue (USD Million) (2017-2018)
Table 106. Laboratoires Thea SWOT Analysis
Table 107. Laboratoires Thea Eye Drug Product and Services
Table 108. Laboratoires Thea Eye Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 109. Global Eye Drug Sales by Manufacturer (2018-2019) (MT)
Table 110. Global Eye Drug Revenue by Manufacturer (2018-2019) (USD Million)
Table 111. Global Eye Drug Sales by Regions (2015-2020) (MT)
Table 112. Global Eye Drug Sales Market Share by Regions (2015-2020)
Table 113. Global Eye Drug Revenue by Regions (2015-2020) (USD Million)
Table 114. North America Eye Drug Sales by Countries (2015-2020) (MT)
Table 115. North America Eye Drug Sales Market Share by Countries (2015-2020)
Table 116. North America Eye Drug Revenue by Countries (2015-2020) (USD Million)
Table 117. North America Eye Drug Revenue Market Share by Countries (2015-2020)
Table 118. Europe Eye Drug Sales by Countries (2015-2020) (MT)
Table 119. Europe Eye Drug Sales Market Share by Countries (2015-2020)
Table 120. Europe Eye Drug Revenue by Countries (2015-2020) (USD Million)
Table 121. Asia-Pacific Eye Drug Sales by Regions (2015-2020) (MT)
Table 122. Asia-Pacific Eye Drug Sales Market Share by Regions (2015-2020)
Table 123. Asia-Pacific Eye Drug Revenue by Regions (2015-2020) (USD Million)
Table 124. South America Eye Drug Sales by Countries (2015-2020) (MT)
Table 125. South America Eye Drug Sales Market Share by Countries (2015-2020)
Table 126. South America Eye Drug Revenue by Countries (2015-2020) (USD Million)
Table 127. South America Eye Drug Revenue Market Share by Countries (2015-2020)
Table 128. Middle East & Africa Eye Drug Sales by Countries (2015-2020) (MT)
Table 129. Middle East & Africa Eye Drug Sales Market Share by Countries (2015-2020)
Table 130. Middle East & Africa Eye Drug Revenue by Countries (2015-2020) (USD Million)
Table 131. Middle East & Africa Eye Drug Revenue Market Share by Countries (2015-2020)
Table 132. Global Eye Drug Sales by Type (2015-2020) (MT)
Table 133. Global Eye Drug Sales Share by Type (2015-2020)
Table 134. Global Eye Drug Revenue by Type (2015-2020) (USD Million)
Table 135. Global Eye Drug Revenue Share by Type (2015-2020)
Table 136. Global Eye Drug Sales by Application (2015-2020) (MT)
Table 137. Global Eye Drug Sales Share by Application (2015-2020)
Table 138. Global Eye Drug Sales Forecast by Regions (2021-2025) (MT)
Table 139. Global Eye Drug Market Share Forecast by Regions (2021-2025)
Table 140. Global Eye Drug Sales Forecast by Type (2021-2025) (MT)
Table 141. Global Eye Drug Market Share Forecast by Type (2021-2025)
Table 142. Global Eye Drug Sales Forecast by Application (2021-2025)
Table 143. Global Eye Drug Market Share Forecast by Application (2021-2025)
Table 144. Direct Channel Pros & Cons
Table 145. Indirect Channel Pros & Cons
Table 146. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Eye Drug Picture
Figure 2. Global Sales Market Share of Eye Drug by Type in 2019
Figure 3. Drops Picture
Figure 4. Tablet & Capsule Picture
Figure 5. Eye Drug Sales Market Share by Application in 2018
Figure 6. Glaucoma Picture
Figure 7. Retinal Disease Picture
Figure 8. Bacterial?Infection Picture
Figure 9. Other Picture
Figure 10. Global Eye Drug Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Eye Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Eye Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Eye Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Eye Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Eye Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Eye Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Eye Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Eye Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Eye Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Eye Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Eye Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Eye Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Eye Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Eye Drug Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Eye Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Eye Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Eye Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Eye Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Eye Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Eye Drug Sales Market Share by Manufacturer in 2019
Figure 31. Global Eye Drug Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Eye Drug Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Eye Drug Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Eye Drug Sales and Growth Rate (2015-2020) (MT)
Figure 36. Global Eye Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Eye Drug Revenue Market Share by Regions (2015-2020)
Figure 38. Global Eye Drug Revenue Market Share by Regions in 2018
Figure 39. North America Eye Drug Sales and Growth Rate (2015-2020)
Figure 40. Europe Eye Drug Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Eye Drug Sales and Growth Rate (2015-2020)
Figure 42. South America Eye Drug Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Eye Drug Sales and Growth Rate (2015-2020)
Figure 44. North America Eye Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Eye Drug Sales Market Share by Countries (2015-2020)
Figure 46. North America Eye Drug Sales Market Share by Countries in 2018
Figure 47. North America Eye Drug Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Eye Drug Revenue Market Share by Countries in 2018
Figure 49. United States Eye Drug Sales and Growth Rate (2015-2020) (MT)
Figure 50. Canada Eye Drug Sales and Growth Rate (2015-2020) (MT)
Figure 51. Mexico Eye Drug Sales and Growth Rate (2015-2020) (MT)
Figure 52. Europe Eye Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Eye Drug Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Eye Drug Revenue Market Share by Countries in 2019
Figure 55. Germany Eye Drug Sales and Growth Rate (2015-2020) (MT)
Figure 56. UK Eye Drug Sales and Growth Rate (2015-2020) (MT)
Figure 57. France Eye Drug Sales and Growth Rate (2015-2020) (MT)
Figure 58. Russia Eye Drug Sales and Growth Rate (2015-2020) (MT)
Figure 59. Italy Eye Drug Sales and Growth Rate (2015-2020) (MT)
Figure 60. Asia-Pacific Eye Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Eye Drug Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Eye Drug Revenue Market Share by Regions 2019
Figure 63. China Eye Drug Sales and Growth Rate (2015-2020) (MT)
Figure 64. Japan Eye Drug Sales and Growth Rate (2015-2020) (MT)
Figure 65. Korea Eye Drug Sales and Growth Rate (2015-2020) (MT)
Figure 66. India Eye Drug Sales and Growth Rate (2015-2020) (MT)
Figure 67. Southeast Asia Eye Drug Sales and Growth Rate (2015-2020) (MT)
Figure 68. South America Eye Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Eye Drug Sales Market Share by Countries in 2019
Figure 70. South America Eye Drug Revenue Market Share by Countries in 2019
Figure 71. Brazil Eye Drug Sales and Growth Rate (2015-2020) (MT)
Figure 72. Argentina Eye Drug Sales and Growth Rate (2015-2020) (MT)
Figure 73. Middle East and Africa Eye Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Eye Drug Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Eye Drug Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Eye Drug Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Eye Drug Sales and Growth Rate (2015-2020) (MT)
Figure 78. Egypt Eye Drug Sales and Growth Rate (2015-2020) (MT)
Figure 79. Turkey Eye Drug Sales and Growth Rate (2015-2020) (MT)
Figure 80. South Africa Eye Drug Sales and Growth Rate (2015-2020) (MT)
Figure 81. Global Eye Drug Sales and Growth Rate (2021-2025) (MT)
Figure 82. Global Eye Drug Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Eye Drug Market Forecast (2021-2025) (MT)
Figure 84. Europe Sales Eye Drug Market Forecast (2021-2025) (MT)
Figure 85. Asia-Pacific Sales Eye Drug Market Forecast (2021-2025) (MT)
Figure 86. South America Sales Eye Drug Market Forecast (2021-2025) (MT)
Figure 87. Middle East & Africa Sales Eye Drug Market Forecast (2021-2025) (MT)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
クローン病治療薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Crohn’s Disease Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Crohn’s Disease Drug mar…- 胃食道逆流症（GERD）薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Gastro Esophageal Reflux Disease (GERD) Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The …
- 眼科用薬品の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Ophthalmol Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Ophthalmol Drug market report…
- アレルギー鼻炎薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Allergy Rhinitis Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Allergy Rhinitis Drug m…
- 併用療法薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Combination Therapy Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Combination Therapy …